The new contraceptive revolution: developing innovative products outside of industry,.

Callahan, Rebecca L; Mehta, Neha J; Nanda, Kavita; Kopf, Gregory S

The new contraceptive revolution: developing innovative products outside of industry,.

Callahan, Rebecca L; Mehta, Neha J; Nanda, Kavita; Kopf, Gregory S.

Afiliación

Callahan RL; Reproductive Health Product Innovation & Introduction, Global Health Population & Nutrition, FHI 360, Durham, NC, USA.
Mehta NJ; Reproductive Health Product Innovation & Introduction, Global Health Population & Nutrition, FHI 360, Durham, NC, USA.
Nanda K; Reproductive Health Product Innovation & Introduction, Global Health Population & Nutrition, FHI 360, Durham, NC, USA.
Kopf GS; Reproductive Health Product Innovation & Introduction, Global Health Population & Nutrition, FHI 360, Durham, NC, USA.

Biol Reprod ; 103(2): 157-166, 2020 08 04.

Article en En | MEDLINE | ID: mdl-32529250

Asunto(s)

Anticoncepción; Anticonceptivos; Desarrollo de Medicamentos; Humanos

Palabras clave

acceptability; clinical trial; first-in-human; market research; pharmaceutical development; preclinical development; regulatory strategy; target product profile; user preferences

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Anticoncepción / Anticonceptivos / Desarrollo de Medicamentos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biol Reprod Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google